North America Biomaterials Market worth $27.89 billion by 2030

The report "North America Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030" is projected to grow from USD 19.44 billion in 2025 and to reach USD 27.89 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.

Browse 308 market data Tables and 25 Figures spread through 280 Pages and in-depth TOC on "North America Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-biomaterials-market-142457278.htm

The North American biomaterials market is experiencing growth, driven by several key factors, including increasing innovations in smart, biocompatible, and 3D-printed biomaterials, as well as advanced healthcare infrastructure.

The metallic biomaterials segment accounted for the largest share of the North America biomaterials market in 2024.

Based on type, the biomaterials market is segmented into metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver, magnesium, and other metallic biomaterials), polymeric (polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, polyetheretherketone, other polymeric biomaterials), ceramic (calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon, and glass), and natural (hyaluronic acid, collagen, fibrin, cellulose, chitin, alginate, gelatin, chitosan, silk, other natural biomaterials). The metallic biomaterials segment accounted for the largest share of the biomaterials market in 2024. The dominant share of this segment primarily relates to the widespread use of metals in the manufacturing of medical devices, including cardiovascular, dental, and orthopedic devices. The increasing number of elderly individuals worldwide is expected to raise the demand for medical devices, as older individuals are more vulnerable to orthopedic, dental, ophthalmologic, neurological, and cardiovascular diseases.

In 2024, the orthopedic segment is expected to be the fastest-growing in the North America biomaterials market, by application.

The North America biomaterials market is segmented by application into orthopedic, cardiovascular, dental, plastic surgery, urinary applications, wound healing, tissue engineering, ophthalmology, neurological/central nervous system, and other applications. In 2024, the orthopedic segment accounted for the largest share of the North America biomaterials market. The large share of this segment can be attributed to the growing number of orthopedic disorders, like osteoarthritis, osteoporosis, and musculoskeletal injuries. Biomaterial technologies have also contributed to the development of innovative materials that exhibit improved biocompatibility, durability, and mechanical properties, enhancing their applications in orthopedic surgery and care.

The US accounted for the largest share of the North America biomaterials market in 2024.

The North America biomaterials market is primarily divided into the US and Canada, with the US holding the largest share of regional revenues and serving as the main driver of growth. This dominance is due to the concentration of medical device and biopharma headquarters, academic medical centers, and specialized surgical and research hospitals in the country. Additionally, strong FDA oversight and rapid adoption of advanced biomaterial technologies, such as implants, regenerative materials, and drug-eluting devices, further enhance the US’ position. The country also benefits from a large pipeline of orthopedic, cardiovascular, and dental implants, substantial NIH and venture funding for regenerative medicine, and a vibrant clinical trials ecosystem, all of which solidify the US as the leading hub for biomaterial innovation in North America. Meanwhile, Canada plays a smaller yet significant role, supported by expanding hospital infrastructure and increasing investments in tissue engineering and the manufacturing of polymeric biomaterials.

Key players in the North America biomaterials market include BASF SE (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), AMETEK Inc. (US), Berkeley Advanced Biomaterials (US), Zeus Company Inc. (US), CoorsTek, Inc. (US), and The RDI Group (US).

Don’t miss out on business opportunities in North America Biomaterials Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar

MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2026 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
...

Digital Virtual Assistant - MarketsandMarkets

Home